Anastomosis
The join made when two ends of bowel are reconnected after part has been removed.
Also called: anastomoses, bowel join, join, reconnection, anastomotic
Related words resection post-operative recurrence
Topics Surgery
The join made when two ends of bowel are reconnected after part has been removed.
Also called: anastomoses, bowel join, join, reconnection, anastomotic
Related words resection post-operative recurrence
Topics Surgery
Yes. Crohn's & Colitis UK says Crohn's may return after surgery; doctors often check the area around the bowel join with a colonoscopy. NICE suggests azathioprine, often with up to three months of metronidazole, after a complete ileocolonic resection. The POCER trial and a Cochrane review support checking with a colonoscopy after surgery and stepping up treatment if needed. The 2025 BSG guideline suggests offering early advanced treatment, especially to people at higher risk, such as smokers.
Sources
Crohn's & Colitis UK explains that a strictureplasty widens a narrowed (scarred) section of small bowel without removing any bowel. A resection removes the damaged section and joins the healthy ends. An ileocaecal resection removes the end of the small bowel and the start of the large bowel, a common site for Crohn's. Many of these operations can be done by keyhole surgery.
Source
No. Crohn's & Colitis UK explains that 'terminal' here simply means 'end'. The terminal ileum is the last part of the small bowel, where it joins the large bowel, and it is one of the most common places for Crohn's to appear. If it also involves the start of the large bowel, it may be called ileocaecal or ileocolonic Crohn's.
Sources
Ask your IBD team whether your hospital is running any studies. You can also search the NIHR's Be Part of Research website, which lists UK studies currently recruiting people with Crohn's. The IBD BioResource invites people with Crohn's or colitis to join a national panel and be contacted about future studies. Crohn's & Colitis UK also lists ways to help shape research, such as patient and public involvement.
Sources
The second half of the European Crohn's guideline, about operations. It covers getting ready for surgery, what to do with medicines beforehand, and practical technical advice for surgeons in common situations such as narrowed bowel, abscesses and fistulas. Useful if you want to understand why a surgeon recommends a particular approach.
Topics Surgery Around the bottom (perianal) Complications
Jargon explained resection stricture fistula abscess preoperative optimisation anastomosis
A trial of how to stop Crohn's returning after bowel surgery. Treating people according to their risk, checking with a colonoscopy at six months and stepping up treatment if the disease had come back worked better than standard drug treatment alone. It also showed that even low-risk patients need monitoring.
Topics Surgery Monitoring Research
Jargon explained post-operative recurrence colonoscopy step-up resection
A Cochrane review suggesting that stepping up treatment based on a colonoscopy after surgery may reduce Crohn's coming back compared with waiting for symptoms. Whether to start treatment immediately after surgery or only after a colonoscopy remains uncertain.
Topics Surgery Monitoring Research
Jargon explained post-operative recurrence colonoscopy prophylaxis
A factsheet for people given the antibiotic metronidazole after bowel surgery for Crohn's. It explains that national guidance suggests a three-month course may help stop Crohn's returning after surgery, and covers side effects.
Jargon explained metronidazole resection post-operative recurrence
The NHS research service's search tool for finding health studies to take part in across the UK. Searching for Crohn's disease lists studies currently recruiting, with who can join and where. A good first stop if you want to volunteer for a trial.
Topics Research
Jargon explained clinical trial recruiting
The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.
Topics Research
Jargon explained clinical trial randomised
Looks at whether azathioprine or mercaptopurine help stop Crohn's coming back after an operation. The evidence is weak: they may be a little better than placebo, may cause more side effects than mesalazine-type drugs, and may be less effective than anti-TNF biologics, but no firm conclusions can be drawn.
Topics Immunosuppressants Surgery Research
Jargon explained postoperative recurrence low certainty evidence post-operative recurrence thiopurine 5-ASA anti-TNF
The largest worldwide database of clinical studies, run by the US government. It includes many trials running at UK hospitals, often drug-company trials of new Crohn's medicines. Each record lists the study's aim, who can join and where.
Topics Research
Jargon explained clinical trial eligibility criteria trial registry NCT number
The UK registry that collects health data from people with IBD to help improve care and support research. It has been running since 2012 and joined NHS England in 2026. Hospital teams use it to compare their services, and people with IBD can find out what data is collected about them.
Topics Research Monitoring
Jargon explained registry quality improvement
IBD UK's 2021 report, drawing on more than 10,000 patients and most UK IBD services. It found people waited too long for diagnosis, pain, fatigue and emotional wellbeing were often ignored, specialist help was slow, there were too few IBD nurses, dietitians and psychologists, and care was often not joined up.
Topics Research Living well Diagnosis and tests
Jargon explained benchmarking IBD nurse specialist
Compares the medicines used to stop Crohn's returning after an operation. The evidence was not strong enough to say which works best. Cases of pancreatitis and low white blood cell counts were seen with azathioprine-type drugs.
Jargon explained network meta-analysis endoscopic relapse postoperative recurrence
A readable summary of what the 2025 BSG guideline says about Crohn's. Key points: early 'top-down' infliximab with an immunomodulator for moderate to severe disease; avoiding long or repeated steroid courses; no longer suggesting immunomodulators alone; upadacitinib and risankizumab added; vedolizumab no longer routinely suggested; drug-level testing for anti-TNFs; early surgery as an option for limited ileocaecal disease; and offering early treatment after resection.
Topics Medicines Surgery Monitoring
Jargon explained top-down step-up therapeutic drug monitoring ileocaecal resection Rutgeerts score immunogenicity